These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 8370576)

  • 1. Relation of cardiovascular risk factors to atherosclerosis in type III hyperlipoproteinemia.
    Feussner G; Wagner A; Ziegler R
    Hum Genet; 1993 Sep; 92(2):122-6. PubMed ID: 8370576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein (a) phenotypes and lipoprotein (a) concentrations in patients with type III hyperlipoproteinaemia.
    Feussner G; Feussner V; Ziegler R
    J Intern Med; 1994 May; 235(5):425-30. PubMed ID: 8182397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of type III hyperlipoproteinemia: analysis of 64 patients.
    Feussner G; Wagner A; Kohl B; Ziegler R
    Clin Investig; 1993 May; 71(5):362-6. PubMed ID: 8508005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoproteins of special significance in atherosclerosis. Insights provided by studies of type III hyperlipoproteinemia.
    Mahley RW; Innerarity TL; Rall SC; Weisgraber KH
    Ann N Y Acad Sci; 1985; 454():209-21. PubMed ID: 3000263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III hyperlipoproteinemia in a child with hemolytic uremic syndrome.
    Feussner G; Wingen AM; Ziegler R
    Metabolism; 1990 Nov; 39(11):1196-9. PubMed ID: 2233282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dyslipidemia and accelerated atherosclerosis.
    Hazzard WR
    Hosp Pract (Off Ed); 1988 May; 23(5A):41-50. PubMed ID: 2967303
    [No Abstract]   [Full Text] [Related]  

  • 7. Lipoprotein(a) in childhood: relation with other atherosclerosis risk factors and family history of atherosclerosis.
    Bailleul S; Couderc R; Rossignol C; Fermanian J; Boutouchent F; Farnier MA; Etienne J
    Clin Chem; 1995 Feb; 41(2):241-5. PubMed ID: 7874778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of apolipoprotein E polymorphism on plasma lipid and apolipoprotein levels, and clinical characteristics of type III hyperlipoproteinemia due to apolipoprotein E phenotype E2/2 in Japan.
    Kobori S; Nakamura N; Uzawa H; Shichiri M
    Atherosclerosis; 1988 Jan; 69(1):81-8. PubMed ID: 3355609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia.
    Feussner G; Dobmeyer J; Nissen H; Hansen TS
    Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two Italian kindreds carrying the Arg136-->Ser mutation of the Apo E gene: development of premature and severe atherosclerosis in the presence of epsilon 2 as second allele.
    Rolleri M; Vivona N; Emmanuele G; Cefalù AB; Pisciotta L; Guido V; Noto D; Fiore B; Barbagallo CM; Notarbartolo A; Travali S; Bertolini S; Averna MR
    Nutr Metab Cardiovasc Dis; 2003 Apr; 13(2):93-9. PubMed ID: 12929622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hereditary changes of apolipoproteins B and E].
    Gaeta G; Effuso L; Maurea N; Boccalatte M; Antignano A; Sifola C; Scala R
    Clin Ter; 1994 Jun; 144(6):527-37. PubMed ID: 8001338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [From gene to disease; apolipoprotein E2 and familial dysbetalipoproteinemia].
    Smelt AH
    Ned Tijdschr Geneeskd; 2003 Jan; 147(4):157-9. PubMed ID: 12635547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of apolipoprotein E3 deficiency (E2/2 phenotype) associated with renovascular hypertension and atherosclerosis obliterans].
    Chiao S; Nozaki S; Hara H; Nakajima T; Kameda K; Kubo M; Tokunaga K; Hirobe K; Matsuzawa Y; Tarui S
    Nihon Naika Gakkai Zasshi; 1984 Dec; 73(12):1805-10. PubMed ID: 6533213
    [No Abstract]   [Full Text] [Related]  

  • 14. A novel apolipoprotein E2 variant, E2Toranomon (Q187E), identified in a type III hyperlipoproteinemia patient with coronary atherosclerosis.
    Okubo M; Aoyama Y; Harada K; Fukawa M; Tsukada T; Mokuno H; Yamada N; Murase T
    Atherosclerosis; 1998 Sep; 140(1):187-90. PubMed ID: 9733231
    [No Abstract]   [Full Text] [Related]  

  • 15. Apolipoproteins and atherosclerosis. Apolipoprotein E and apolipoprotein(a) as candidate genes of premature development of atherosclerosis.
    Horejsí B; Ceska R
    Physiol Res; 2000; 49 Suppl 1():S63-9. PubMed ID: 10984073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apolipoprotein epsilon 2/3 genotype and type III hyperlipoproteinemia among Taiwanese.
    Lin HP; Kao JT
    Clin Chim Acta; 2003 Apr; 330(1-2):173-8. PubMed ID: 12636937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apolipoprotein E3-Leiden. A new variant of human apolipoprotein E associated with familial type III hyperlipoproteinemia.
    Havekes L; de Wit E; Leuven JG; Klasen E; Utermann G; Weber W; Beisiegel U
    Hum Genet; 1986 Jun; 73(2):157-63. PubMed ID: 3721502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics of type III hyperlipoproteinemia.
    Feussner G; Piesch S; Dobmeyer J; Fischer C
    Genet Epidemiol; 1997; 14(3):283-97. PubMed ID: 9181357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of family history of atherosclerosis with atherogenic lipid traits in men with non-coronary atherosclerosis.
    Sentí M; Pedro-Botet J; Pavesi M; Marrugat J; Aubó C; Pena A; Martín S; Rubiés-Prat J
    Clin Chim Acta; 1997 Aug; 264(2):193-205. PubMed ID: 9293377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type III hyperlipoproteinemia with xanthomas and multiple myeloma.
    Burnside NJ; Alberta L; Robinson-Bostom L; Bostom A
    J Am Acad Dermatol; 2005 Nov; 53(5 Suppl 1):S281-4. PubMed ID: 16227109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.